Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
1
x
$
0.00
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
1
x
$
30.00
Table of Contents, Vol 47, No. 2, 2017
1
x
$
0.00
C. Philip O’Carroll, MD: Migraine And The Limbic System: Closing The Circle
1
x
$
30.00
View Cart
Checkout
Home
Store
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis
$
30.00
Add to cart
Details
Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID-Putting the Cart before the Horse?
$
30.00
Add to cart
Details
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis
$
30.00
Add to cart
Details
A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5–12
$
30.00
Add to cart
Details
Alzheimer’s and Dementia Guidelines and Tables
$
30.00
Add to cart
Details
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
$
30.00
Add to cart
Details
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
$
30.00
Add to cart
Details
El libro negro de dosificación y monitoreo de sustancias psicotrópicas
$
30.00
Add to cart
Details
Thomas J. Raedler, MD: Lithium-Induced Nephropathies
$
30.00
Add to cart
Details
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
$
30.00
Add to cart
Details
Off-Label Second Generation Antipsychotics for Impulse Regulation Disorders: A Review
$
30.00
Add to cart
Details
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
$
30.00
Add to cart
Details
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
$
30.00
Add to cart
Details
Caso clínico: Koro en trastorno esquizofreniforme
$
0.00
Add to cart
Details
A Case of Hyper Sexuality Probably Associated with Clozapine
$
30.00
Add to cart
Details
Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks
$
30.00
Add to cart
Details
The Use of Prazosin in Treatment of Drug Dreams in Adolescents with Substance Use Disorder: Two Case Reports (OPEN ACCESS)
$
0.00
Add to cart
Details
Adverse Effects of Recreational and Medical Cannabis
$
30.00
Add to cart
Details
ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!
$
30.00
Add to cart
Details
Previous
1
…
38
39
40
…
44
Next
Page load link
Go to Top
